AARDVARK THERAPEUTICS, INC. (AARD) Free cash flow 2024–2025
AARDVARK THERAPEUTICS, INC. (AARD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$54.3MFY2025 · since FY2024: -$18.2M → -$54.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.3M | -198.2% |
| FY2024 | -$18.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice